Septerna Inc
$36.57
The Read: Septerna's stock rose sharply on strong Q1 earnings beats and positive Phase 1 data for SEP-631 and SEP-479, but earlier delays in Phase 2b trial timing for SEP-631 caused a 13.5% drop.
Price
Overlays
Panel
SEPN
Hover to view data
No Data